ADARx Pharmaceuticals, Inc. (ADRX)
12.67
-1.49
(-10.52%)
USD |
NASDAQ |
Nov 20, 16:00
12.67
0.00 (0.00%)
After-Hours: 16:05
ADARx Pharmaceuticals Total Liabilities (Quarterly) : 354.66M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 354.66M |
| June 30, 2026 | 349.76M |
| Date | Value |
|---|---|
| March 31, 2026 | 350.67M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 45.56M |
| IRulya Therapeutics, Inc. | 28.37M |
| PepGen Inc. | 24.71M |
| Q32 Bio, Inc. | 9.531M |
| Bridgebio Oncology Therapeutics, Inc. | 52.84M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 929.06M |
| Shareholders Equity (Quarterly) | 574.40M |
| Debt to Equity Ratio | 0.0112 |
| Current Ratio | 21.08 |
| Net Debt Paydown Yield | -0.03% |